Resources

The Latest from

  • June 17, 2022
    HOLX – Base Case iCDS 127bps, Negative Case iCDS 241bps, 2028 4.625% Bond YTW of 5.919%, iYTW of 4.769%, Ba1 Rating from Moody’s, IG4 (equivalent to Baa2) Rating from Valens, Low Refinancing Need

    HOLX – Base Case iCDS 127bps

    Negative Case iCDS 241bps, 2028 4.625% Bond YTW of 5.919%, iYTW of 4.769%

    Ba1 Rating from Moody’s, IG4 (equivalent to Baa2) Rating from Valens

    Low Refinancing Need...

    Read More

  • June 15, 2022
    Valens Credit Weekly Insights for June 15, 2022

    Featured Top Idea
    GM – General Motors Company
    Action: Buy 2027 6.800% Bonds CUSIP: 37045VAU4 (5.206% YTW, 3.796% iYTW)
    Buy 2028 5.000% Bonds CUSIP: 37045VAS9 (5.496% YTW, 4.103% iYTW)...

    Read More

  • June 14, 2022
    Valens Equity Weekly Insights for June 14, 2022

    Acuity Brands, Inc. (AYI) is the best positioned company to implement smart, connected lighting solutions as more companies and individuals look to adopt more IoT solutions. It is making smart investments into platforms to support its lighting solutions. Uniform Accounting highlights that the market is pricing in a reversal of recent profitability expansion, but management is confident about its momentum and is aligned to continue executing on improving profitability, signaling the potential for equity upside as the company continues executing....

    Read More

  • June 8, 2022
    Valens Credit Weekly Insights for June 8, 2022

    Featured Top Idea
    CC – The Chemours Company

    Read More

  • June 7, 2022
    Valens Equity Weekly Insights and Inflections for June 7, 2022

    Aramark (ARMK) managed to survive during the pandemic, and now it has an opportunity to further consolidate the $900 billion food, facilities, and uniform management industry. Uniform Accounting highlights that the market is not pricing in this recovery. Considering management’s strong execution and alignment to continue executing, equity upside is warranted...

    Read More

  • You don’t have access to the Valens Research Premium Application.

    To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email client.relations@valens-research.com.

    Please fill out the fields below so that our client relations team can contact you

    Or contact our Client Relationship Team at 630-841-0683

    Action: Buy 2027 5.375% Bonds, CUSIP: 163851AE8 (6.233% YTW, 4.133% iYTW)
    Buy 2028 5.750% Bonds, CUSIP: 163851AF5 (6.395% YTW, 4.145% iYTW)